Issue link: http://osercommunicationsgroup.uberflip.com/i/858133
Chain Drugstore Daily 6 1 Tuesday, August 22, 2017 PM: Our focus as a team is to identify the needs and wants of our customer and then go out and find businesses to satisfy those needs. We have diverse product knowledge and expertise across all cate- gories in both national brands and store brands. We take a collaborative, team approach to all businesses to ensure there is always someone working for the cus- tomer as well as our manufacturers. CDD: How is your company handling the rise of digital? PM: There is a wave of change reshaping retail, and we are focused on how to do business differently. Our goal is not only to maintain our retail customer base, but to grow it as well. This will be accom- plished through value-added programs, personalization, direct mail and specialty services designed to drive the consumer to stores. The only constant in business is change, and it's all about bringing for- ward new ideas and approaches to win at shelf. Middlebridge Marketing (Cont'd. from p. 1) CDD: How does Middlebridge Marketing make an impact on the cus- tomer as well as the manufacturers? PM: Value added is the key to success with our customers as well as our manu- facturers. We not only sell in, we sell through. We create programs that include all of the initiatives that the retailer has to offer and combine them with the manu- facturer's, creating a 360 degree integrat- ed plan. CDD: Middlebridge Marketing is approaching 28 years in business. What have been the key factors to this longevi- ty? PM: We pride ourselves on our relation- ships and the passion to win. Simply said, it's our team approach, keeping pace with change and delivering best in class results. For more information, contact Patrick at 401.728.0040 or patrickm@middlebridge mktg.com, or learn more at www .middlebridgemktg.com. competitive intelligence includes list price, off-invoice allowances, bill back allowances, payment terms and more and is captured for more than 60 HBW cate- gories. "Companies today have access to more data than ever before, and in fact, many are overwhelmed with excessive and non-relevant data," says Glenwood Davis, CPR's President and Chief Executive Officer. "The challenge our clients face is mining through this data to identify meaningful and relevant insights." "CPR provides our clients with actionable competitive trade spending and pricing solutions that drive improved category/brand ROI via two distinct plat- forms. The heart of the company's syndi- cated solutions platform is our CPR Detail Report. This one-of-a-kind trade spending and pricing tool allows our clients to analyze both national brand and store brand trade pricing and promotion- al spending activity by SKU, by brand/product, by segment and/or by cat- egory. Using the CPR Detail Report, clients are able to better strategically position their brands and SKUs relative to those of their competitors with their key retail customers. This report also gives clients the ability to quickly identi- fy list price changes and to track promo- tional pricing trends over time, thus giv- ing them a clear, competitive advantage in the marketplace. By benchmarking and understanding your competitive trade pricing and promotions, manufac- turers are able to identify and establish optimal list prices, and can better under- stand when price changes are appropri- ate," Davis added. CPR's Integrated Data Management (IDM) platform leverages CPR's propri- etary trade pricing and spending data along with customer POS syndicated data provided by their clients to help them fully understand their brand role and financial contribution to the retailer's bottom line. IDM considers multiple Competitive Promotion Report (Cont'd. from p. 1) metrics in context with the retailers' mar- gin objectives to understand how various strategies can impact their brand, the competitor's brands and even Store Brand's Return on Investment (ROI). Key components of CPR's IDM platform include: Brand Profitability Comparison Analysis. What is the total margin dollar contribution, margin percent and penny profit and margin per point of distribu- tion for your brand versus competitive brands? Trade Spending Analysis. Considering off-invoice and bill back allowances, how much are you spending in the trade to support your brand versus your competitors? Portfolio Optimization (National and Store Brand). What specific promotional activities and price gap optimizes margin for the retailer? Strategic Pricing Analysis. A five to 10 year analysis of list price changes in a category to identify trends by your com- petitors to help manufacturers use fact- based analysis to establish the optimal pricing strategy. Using national brand published list price and private label's EDAC (Every Day Acquisition Cost) from the CPR database along with retail pricing from other syndicated services, CPR is able to calculate retailer margin and conduct analysis and modeling to help manufac- turers and retailers identify financial insights otherwise unavailable. Based on these insights, CPR is able to make recommendations that will drive total category margin dollars and market growth. "Our clients are among the leading manufacturers in the industry and have come to depend on CPR for both our syn- dicated database services and IDM analysis and insights," says Davis. For more information, call 770.565.0735, x106 or go to www .competitivepromotion.com. been expanded to support its customers' need for high-quality, high-customer- service contract packaging services for pharmaceuticals and nutritional supple- ments. "Aphena's site expansion in Cookeville reflects our continued com- mitment to support the growing needs of our customers in pharmaceutical and nutritional products," said Eric Allen, Aphena's corporate Vice President – Sales and Marketing. "Our objective is to continue to build upon the current indus- try need for newly approved branded or generic drugs as well as compliance with new federal laws around serialization requirements. Aphena has positioned itself to support significant future volume growth." The expansion almost doubles the size of the FDA- and DEA-inspected facility with significant increases in manufacturing space, warehouse space and DEA storage capacity. Capabilities Aphena Pharma Solutions (Cont'd. from p. 1) now include bottle-packaging lines, blister-packaging lines, secondary- packaging lines, stretch carding, carton- ing, shrink-sleeve labeling, heat-seal carding, kitting and display packaging. The Tennessee location now offers more than 135,000 square feet and 25 production lines dedicated to solid-dose primary and secondary packaging serv- ices. Aphena Pharma Solutions Inc. is an industry-leading organization providing turnkey contract packaging, repackaging and manufacturing solutions for the phar- maceutical, OTC, dietary supplement, animal health, consumer health and med- ical device markets. With two separate FDA- and DEA-registered sites in the U.S., Aphena handles solid dose, liquids, gels, creams, ointments, foams, suspen- sions and lotions. Visit Aphena Pharma at booth #3512. For more information, go to www.aphenapharma.com or call 866.465.4506. of hub, specialty distribution and pharmacy services; improved patient access through reimbursement and patient affordability solutions ranging from co-pay cards to full-service hub support for complex pharmacy and medically reimbursed products; and coordination of access at specialty phar- macies, clinics and retail pharmacies where product is in stock. For emerging pharmaceutical com- panies, the management of this maze of services can be challenging and may start at different points in the supply chain. In many cases, physical storage and distribution are the entry points, for others significant market-access challenges direct initial commercializa- H. D. Smith (Cont'd. from p. 4) tion efforts toward reimbursement solutions. However, the need for flexibility and creativity is not limited to emerging phar- macy companies. Today, each brand launch is unique, and commercial teams should consider new approaches before placing a product into traditional distri- bution models or even established spe- cialty channels. By focusing on each step in a prod- uct's journey, the collective H. D. Smith companies has proven to be a flexible partner that can improve access and reduce program costs through a truly integrated, end-to-end approach. Visit H. D. Smith at booth #3723. For more information, go to www.hd smithcompanies.com. been available for shipment to our cus- tomers since February 1, 2017. We encourage medical professionals, patients and caregivers to reach out to us and find out how we can help." About TAGI Pharma, Inc. and Precision Dose, Inc. "TAGI Pharma, Inc. was established to target the generic retail market," said Anderson, "and our product selection for TAGI Pharma is focused on higher barri- ers to entry and limited competition, where there are market expansion oppor- tunities in the retail market as well as the non-retail sector currently being serviced by Precision Dose." Precision Dose was established in 2003 and continues to work with the products of prescription and non-pre- scription liquid manufacturers, as well as its own products, to add value through its unique unit dose delivery systems, servicing the hospital and long TAGI Pharma (Cont'd. from p. 4) term care markets. "With its unique line of liquid unit dose products, Precision Dose continues to expand market share by meeting cus- tomers' needs to eliminate dispensing errors, improve inventory control and achieve cost containment. We are unique- ly positioned in the marketplace, leverag- ing the customer relationships of both companies, and thereby optimizing the market opportunities for our products," said Robert Koopman, President and Chief Executive Officer of both TAGI Pharma and Precision Dose, Inc. Visit TAGI Pharma at booth #4715. For more information, go to www.tagi pharma.com or email tetrabenazine @tagipharma.com. Kenny Harrington, Vice President of Sales and Marketing can be contacted by calling 815.624.8523 ext. 203 or emailing kharrington@tagi pharma.com. Tom Anderson, Executive President (Business Development inquiries) can be contacted by calling 410.241.2165 or emailing tanderson@tagipharma.com.